明陽智能(601615.SH):GDR招股説明書獲英國金融行為監管局批准並刊發
格隆匯7月8日丨明陽智能(601615.SH)公佈,公司正在申請發行全球存託憑證(Global Depositary Receipts,“GDR”)並在倫敦證券交易所上市。
此次發行的招股説明書(“GDR招股説明書”)於倫敦時間2022年7月8日獲得英國金融行為監管局(Financial Conduct Authority)批准。公司已根據此次發行上市的時間安排刊發已獲批准的GDR招股説明書,英文全文可在以下公司網址中查閲:
http://www.myse.com.cn/en/ashare/info.aspx?itemid=905
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.